| NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action V Jaquet, J Marcoux, E Forest, KG Leidal, S McCormick, Y Westermaier, ... British journal of pharmacology 164 (2b), 507-520, 2011 | 144 | 2011 |
| Virtual screening: An in silico tool for interlacing the chemical universe with the proteome Y Westermaier, X Barril, L Scapozza Methods, 2014 | 60 | 2014 |
| Binding mode prediction and MD/MMPBSA-based free energy ranking for agonists of REV-ERBα/NCoR Y Westermaier, S Ruiz-Carmona, I Theret, F Perron-Sierra, G Poissonnet, ... Journal of computer-aided molecular design 31, 755-775, 2017 | 34 | 2017 |
| Identification of aggregation breakers for bevacizumab (Avastin®) self-association through similarity searching and interaction studies Y Westermaier, M Veurink, T Riis-Johannessen, S Guinchard, R Gurny, ... European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 773-780, 2013 | 16 | 2013 |
| Breaking the aggregation of the monoclonal antibody bevacizumab (Avastin®) by dexamethasone phosphate: Insights from molecular modelling and asymmetrical flow field-flow … M Veurink, Y Westermaier, R Gurny, L Scapozza Pharmaceutical research 30, 1176-1187, 2013 | 16 | 2013 |
| Stabilized antibody preparations and uses thereof R Gurny, L Scapozza, Y Westermaier, M Veurink US Patent US20130028920A1, 2013 | 15 | 2013 |
| Extensive benchmark of rDock as a peptide-protein docking tool D Soler, Y Westermaier, R Soliva Journal of Computer-Aided Molecular Design 33 (7), 613-626, 2019 | 14 | 2019 |
| Synthesis, crystal structure, and in vitro biological evaluation of C-6 pyrimidine derivatives: new lead structures for monitoring gene expression in vivo M Martić, L Pernot, Y Westermaier, R Perozzo, TG Kraljević, S Krištafor, ... Nucleosides, Nucleotides and Nucleic Acids 30 (4), 293-315, 2011 | 11 | 2011 |
| A new N-methyl thymine derivative comprising a dihydroxyisobutenyl unit as ligand for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK) S Krištafor, I Novaković, T Gazivoda Kraljević, S Kraljević Pavelić, P Lučin, ... Bioorganic & medicinal chemistry letters 21 (20), 6161-6165, 2011 | 10 | 2011 |
| Novel mechanism for an old drug: phenazopyridine is a kinase inhibitor affecting autophagy and cellular differentiation O Preynat-Seauve, EBV Nguyen, Y Westermaier, M Héritier, S Tardy, ... Frontiers in Pharmacology 12, 664608, 2021 | 6 | 2021 |
| Free energy methods in ligand design Y Westermaier, RE Hubbard De novo Molecular Design, 373-415, 2013 | 3 | 2013 |
| Building biological relevance into integrative modelling of macromolecular assemblies AE Molza, Y Westermaier, M Moutte, P Ducrot, C Danilowicz, ... Frontiers in Molecular Biosciences 9, 826136, 2022 | 2 | 2022 |
| Stabilized antibody preparations and uses thereof R Gurny, L Scapozza, Y Westermaier, M Veurink US Patent US20130017197A1, 2013 | 2 | 2013 |
| Confounding factors in targeted degradation of short-lived proteins V Vetma, LC Perez, J Elias, A Stingu, A Kombara, T Gmaschitz, N Braun, ... bioRxiv, 2024.02. 19.581012, 2024 | 1 | 2024 |
| Drugit: Crowd-sourcing molecular design of non-peptidic VHL binders T Scott, CAP Smethurst, Y Westermaier, M Mayer, P Greb, R Kousek, ... Chemrxiv, 2023 | | 2023 |
| High-Throughput Prediction of the Impact of Genetic Variability on Drug Sensitivity and Resistance Patterns for Clinically Relevant Epidermal Growth Factor Receptor Mutations … A Suriñach, A Hospital, Y Westermaier, L Jordà, ... J. Chem. Inf. Model. 63 (1), 321–334, 2022 | | 2022 |
| Prediction Of The Impact Of Genetic Variability On Drug Sensitivity For Clinically Relevant EGFR Mutations A Suriñach, A Hospital, Y Westermaier, L Jordà, S Orozco-Ruiz, D Beltrán, ... bioRxiv, 2022 | | 2022 |
| Taste Perception: Molecular Recognition of Food Molecules: Chemical Education Y Westermaier Chimia 75 (6), 552-552, 2021 | | 2021 |
| Inhibitory effect of adenosine monophosphate on bevacizumab (Avastin®) self-association: Identification of aggregation breakers through similarity searching and interaction studies Y Westermaier, M Veurink, T Riis-Johannessen, S Guinchard, R Gurny, ... Intravitreal Formulations Targeting the Retinal Vasculature in Posterior …, 0 | | |
| In Silico Pharmacology in Drug Discovery: Methods for Binding Affinity Prediction, Identifying Y Westermaier | | |
Leonardo ScapozzaUniversity of GenevaVerified email at unige.ch
